Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
MicroRNAs as biomarkers in spinal muscular atrophy
ID
Barbo, Maruša
(
Author
),
ID
Glavač, Damjan
(
Author
),
ID
Jezernik, Gregor
(
Author
),
ID
Ravnik-Glavač, Metka
(
Author
)
PDF - Presentation file,
Download
(1,03 MB)
MD5: C6F1D11CB9A697465E6D178834329190
URL - Source URL, Visit
https://www.mdpi.com/2227-9059/12/11/2428
Image galllery
Abstract
Spinal muscular atrophy (SMA) is a severe neurodegenerative disease caused by the loss of the survival motor neuron (SMN) protein, leading to degeneration of anterior motor neurons and resulting in progressive muscle weakness and atrophy. Given that SMA has a single, well-defined genetic cause, gene-targeted therapies have been developed, aiming to increase SMN production in SMA patients. The SMN protein is likely involved in the synthesis of microRNAs (miRNAs), and dysregulated miRNA expression is increasingly associated with the pathophysiology of SMA. Currently, there is a lack of reliable biomarkers to monitor SMA; therefore, the search for novel SMA biomarkers, including miRNAs, is crucial as reliable tools are needed to track disease progression, predict the response to therapy and understand the different clinical outcomes of available treatments. In this review, we compile data on miRNAs associated with SMA pathogenesis and their potential use as biomarkers. Based on current knowledge, the most frequently deregulated miRNAs between SMA patients and controls, as well as pre- and post-treatment in SMA patients, include miR-1-3p, miR-133a-3p, miR-133b, and miR-206. These findings offer promising possibilities for improving patient classification and monitoring disease progression and response to treatment. Additionally, these findings provide insights into the broader molecular mechanisms and networks of SMA that could inform the development of future therapeutic strategies.
Language:
English
Keywords:
spinal muscular atrophy
,
SMA
,
circulating miRNA
,
biomarkers
,
molecular networks
Work type:
Article
Typology:
1.02 - Review Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
16 str.
Numbering:
Vol. 12, iss. 11, art. 2428
PID:
20.500.12556/RUL-176039
UDC:
577
ISSN on article:
2227-9059
DOI:
10.3390/biomedicines12112428
COBISS.SI-ID:
214140931
Publication date in RUL:
19.11.2025
Views:
92
Downloads:
36
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Biomedicines
Shortened title:
Biomedicines
Publisher:
MDPI
ISSN:
2227-9059
COBISS.SI-ID:
523006745
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
spinalna mišična atrofija
,
SMA
,
cirkulirajoča miRNA
,
biološki označevalci
,
molekularne mreže
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0170
Name:
Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku
Funder:
ARIS - Slovenian Research and Innovation Agency
Funding programme:
Young researchers
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back